Solid Organ Transplantation Rejection Market by Offering, Organ Type, Rejection Type, End-User - Global Forecast 2025-2030- Product Image

Sale

Solid Organ Transplantation Rejection Market by Offering, Organ Type, Rejection Type, End-User - Global Forecast 2025-2030

Report
188 Pages
October 2024
Region: Global
360iResearch™
ID: 5977994

UP TO €684EUR$697USD£571GBP OFF until Dec 31^st 2024

The Solid Organ Transplantation Rejection Market grew from USD 7.79 billion in 2023 to USD 8.15 billion in 2024. It is expected to continue growing at a CAGR of 4.90%, reaching USD 10.89 billion by 2030.

Solid organ transplantation rejection is an immune response that results in the recipient's body attacking the transplanted organ, which poses significant clinical challenges. The necessity for effective treatments is vital, as rejection can result in organ failure and necessitate further transplants or alternative therapies. The application scope envelopes diagnostics, pharmacological interventions, and monitoring technologies that facilitate early detection and intervention, thereby enhancing transplant survival rates. The end-use scope primarily involves hospitals, transplant centers, and research institutions committed to improving post-transplant care. Insightful market growth is largely driven by advancements in immunosuppressive drugs, biomarkers, and non-invasive diagnostic tools; however, challenges such as stringent regulatory landscapes, high treatment costs, and limited availability of donor organs can impede progress. Key opportunities lie in developing personalized medicine that tailors immunosuppressive therapy to individual genetic profiles, thus minimizing side effects and enhancing outcomes. Expanding research into xenotransplantation and leveraging genomic technologies for better donor-recipient matching also present growth avenues. Recommendations to capitalize on these opportunities include strategic partnerships with biotech firms for innovation, enhancing R&D investment in novel therapeutics, and increasing collaboration with regulatory bodies to streamline approval processes. Potential areas of innovation involve CRISPR gene-editing techniques to improve graft tolerance, as well as AI-driven models for predictive analytics in monitoring transplant rejection risks. Market limitations include potential ethical concerns, post-transplant complications, and the risk of opportunistic infections due to immunosuppression. Despite these barriers, the field is ripe for growth through sustained technological advancements and increasing global healthcare expenditure. The market's dynamic nature requires agile strategic moves, with continuous adaptation to scientific breakthroughs and regulatory shifts to ensure competitive advantage and sustainable business growth.

Understanding Market Dynamics in the Solid Organ Transplantation Rejection Market

The Solid Organ Transplantation Rejection Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing number of organ transplants worldwide
- Rising awareness about the advancements in transplantation and rejection management
Market Restraints
- High costs associated with transplantation procedures
Market Opportunities
- Advancements in immunosuppressive treatments and monitoring technologies
- Emergence of genetic testing to improve predicting rejection risks accurately
Market Challenges
- Complexities associated with immunosuppressive therapies

Exploring Porter’s Five Forces for the Solid Organ Transplantation Rejection Market

Porter’s Five Forces framework further strengthens the insights of the Solid Organ Transplantation Rejection Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Solid Organ Transplantation Rejection Market

External macro-environmental factors deeply influence the performance of the Solid Organ Transplantation Rejection Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Solid Organ Transplantation Rejection Market

The Solid Organ Transplantation Rejection Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Solid Organ Transplantation Rejection Market

The Solid Organ Transplantation Rejection Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Solid Organ Transplantation Rejection Market

The Solid Organ Transplantation Rejection Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Solid Organ Transplantation Rejection Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accord Healthcare Limited, Asahi Kasei Corporation, Astellas Pharma Inc., Biocon, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Eris Lifesciences Ltd., Eurofins Transplant Diagnostics, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Globela Pharma, Lupin Limited, Manus Aktteva Biopharma LLP, Natco Pharma Ltd., Novartis AG, Panacea Biotec Pharma Ltd., Pfizer Inc., Plexision, Sanofi S.A., SAS Alsachim by Shimadzu Group, Strides Pharma Global Pte Ltd., Teva Pharmaceuticals Inc., Thermo Fisher Scientific Inc., Veloxis Pharmaceuticals A/S, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Solid Organ Transplantation Rejection Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offering
- Diagnosis & Testing Solutions
  - Biopsy
  - Blood Tests
  - Imaging Tests
- Medications
  - Antibodies
  - Antimetabolites
  - Calcineurin Inhibitors
  - Steroids
Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Pancreas
Rejection Type
- Acute Rejection
- Chronic Rejection
- Hyperacute Rejection
End-User
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing number of organ transplants worldwide
5.1.1.2. Rising awareness about the advancements in transplantation and rejection management
5.1.2. Restraints
5.1.2.1. High costs associated with transplantation procedures
5.1.3. Opportunities
5.1.3.1. Advancements in immunosuppressive treatments and monitoring technologies
5.1.3.2. Emergence of genetic testing to improve predicting rejection risks accurately
5.1.4. Challenges
5.1.4.1. Complexities associated with immunosuppressive therapies
5.2. Market Segmentation Analysis
5.2.1. Offering: Increasing need for medication to treat the rejection of the transplanted organ
5.2.2. End-User: Extensive use in hospitals for managing solid organ transplantation rejection
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Solid Organ Transplantation Rejection Market, by Offering

6.1. Introduction
6.2. Diagnosis & Testing Solutions
6.3. Medications

7. Solid Organ Transplantation Rejection Market, by Organ Type

7.1. Introduction
7.2. Heart
7.3. Kidneys
7.4. Liver
7.5. Lungs
7.6. Pancreas

8. Solid Organ Transplantation Rejection Market, by Rejection Type

8.1. Introduction
8.2. Acute Rejection
8.3. Chronic Rejection
8.4. Hyperacute Rejection

9. Solid Organ Transplantation Rejection Market, by End-User

9.1. Introduction
9.2. Hospitals
9.3. Specialty Clinics

10. Americas Solid Organ Transplantation Rejection Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Solid Organ Transplantation Rejection Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Solid Organ Transplantation Rejection Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Pioneering Partnership Targets Breakthrough in Organ Transplant Rejection Prevention
13.3.2. New Development in Post-Transplant Monitoring: Real-Time Electronic Organ Health Tracker
13.3.3. GenDx Acquires Licensing for cfDNA Assay from Torino University to Enhance Lung Transplant Monitoring
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio

List of Figures

FIGURE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET RESEARCH PROCESS
FIGURE 2. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SOLID ORGAN TRANSPLANTATION REJECTION MARKET DYNAMICS
FIGURE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. SOLID ORGAN TRANSPLANTATION REJECTION MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 96. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 97. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 98. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 99. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 100. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 101. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 102. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 103. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 104. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 105. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 108. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 109. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 110. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 111. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 112. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 113. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 114. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 115. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 116. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 117. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 155. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 156. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 160. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 161. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 162. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 163. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 164. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 165. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 166. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 167. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 168. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 169. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 172. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 173. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 174. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 175. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 176. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 177. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 178. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 179. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 180. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 181. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 191. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 192. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 196. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 197. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 198. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 199. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 200. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 201. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 202. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 203. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 204. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 205. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 215. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 216. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 227. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 228. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 239. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 240. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 252. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 263. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 264. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 268. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 269. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 270. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 271. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 272. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 273. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 274. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 275. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 276. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 277. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 285. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
TABLE 286. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
TABLE 287. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
TABLE 288. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
TABLE 289. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLIO

Companies Mentioned

The leading players in the Solid Organ Transplantation Rejection market, which are profiled in this report, include:

Abbott Laboratories
Accord Healthcare Limited
Asahi Kasei Corporation
Astellas Pharma Inc.
Biocon
Cipla Ltd.
Dr. Reddy’s Laboratories Ltd.
Eris Lifesciences Ltd.
Eurofins Transplant Diagnostics
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Globela Pharma
Lupin Limited
Manus Aktteva Biopharma LLP
Natco Pharma Ltd.
Novartis AG
Panacea Biotec Pharma Ltd.
Pfizer Inc.
Plexision
Sanofi S.A.
SAS Alsachim by Shimadzu Group
Strides Pharma Global Pte Ltd.
Teva Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Veloxis Pharmaceuticals A/S
Zydus Lifesciences Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 8.15 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.89 Billion
Compound Annual Growth Rate	4.9%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3481EUR$3,545USD£2,904GBP €3868EUR$3,939USD£3,227GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6158EUR$6,272USD£5,138GBP €6843EUR$6,969USD£5,709GBP

Understanding Market Dynamics in the Solid Organ Transplantation Rejection Market

Exploring Porter’s Five Forces for the Solid Organ Transplantation Rejection Market

Applying PESTLE Analysis to the Solid Organ Transplantation Rejection Market

Analyzing Market Share in the Solid Organ Transplantation Rejection Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Solid Organ Transplantation Rejection Market

Strategic Recommendations for Success in the Solid Organ Transplantation Rejection Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Tissue And Organ Transplantation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Transplantation Market by Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Application (Organ Transplantation, Tissue Transplantation), End User (Hospitals, Transplantation Centers, and Others), and Region 2024-2032

Transplantation - Global Strategic Business Report

Organ Transplantation Market by Type, End User - Global Forecast 2025-2030

Transplantation Market by Product, Application, End Use - Global Forecast 2025-2030